Report

src

Global Preclinical CRO Market by Product Type (Bioanalysis and DMPK studies, Toxicology testing and Others) and by End-Users/Application (Biopharmaceutical companies, Government and academic institutes, Medical device companies and Others) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 - 2027

 Report Code
 Category
 Published Date
 Pages
 Format
PM-1302
Healthcare
28 April 2020
217
PDF
Press Release

The report on the global preclinical CRO market analyzes complete scenario i.e., existing as well as future visions of global preclinical CRO market. It includes detailed overview of global preclinical CRO market along with market pictures. Additionally, report has included complete data of the various segments in the global preclinical CRO market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global preclinical CRO market report offers in-depth insights, revenue details, and other vital information regarding the global preclinical CRO market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of global preclinical CRO market.

Market Segmentation:
Segmentation by Type Bioanalysis and DMPK studies
Toxicology testing
Others
Segmentation by Application Biopharmaceutical companies
Government and academic institutes
Medical device companies
Others
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, global preclinical CRO market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global preclinical CRO market. It projects the market assessment for the predicted time. Along with all this report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global Preclinical CRO Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each global preclinical CRO market player.
  • Region-wise and country-wise breakdown of the global preclinical CRO market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global preclinical CRO market.
  • Year-on-year growth of the global preclinical CRO market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand-new proposition to embellish global preclinical CRO market and nurture business as it explains current global market as well as future market.
 

Chapter 1 Global Preclinical CRO Market Overview
1.1 Product Overview and Scope of Global Preclinical CRO Market 

Chapter 2 Executive Summary  
2.1 Drivers for Preclinical CRO Market: 
2.2 Restrain for Preclinical CRO Market:
2.3 Opportunity for Preclinical CRO Market: 
2.4 Global Preclinical CRO market, 2015 - 2027
2.5 Global Preclinical CRO market, by Region, 2015 - 2027
2.6 Global Preclinical CRO market, by Type, 2015 - 2027
2.7 Global Preclinical CRO market, by Application, 2015 - 2027

Chapter 3 Global Preclinical CRO Segment by Types (Product Category) 
3.1 Global Preclinical CRO Revenue (USD Million) and Growth Rate (%) Comparison by Types (2015-2020) 
3.2 Global Preclinical CRO Revenue Market Share (%) by Types in 2019
3.3 Bioanalysis and DMPK studies
3.4 Toxicology testing
3.5 Others 

Chapter 4 Global Preclinical CRO Segment by Application 
4.1 Global Preclinical CRO Revenue (USD Million) Comparison by Application (2015-2027) 
4.2 Biopharmaceutical companies
4.3 Government and academic institutes
4.4 Medical device companies
4.5 Others

Chapter 5 Global Preclinical CRO Market by Regions (2015-2027) 
5.1 Global Preclinical CRO Market Size and Growth Rate (%) Comparison by Regions (2015-2027) 
5.2 North America Preclinical CRO Status and Prospect (2015-2027) 
5.3 Europe Preclinical CRO Status and Prospect (2015-2027) 2
5.4 Asia Pacific Preclinical CRO Status and Prospect (2015-2027) 3
5.5 South America Preclinical CRO Status and Prospect (2015-2027) 
5.6 Middle East & Africa Preclinical CRO Status and Prospect (2015-2027) 
5.7 Global Preclinical CRO Market Size (2015-2027) 
            5.7.1 Global Preclinical CRO Revenue Status and Outlook (2015-2027) 
            
Chapter 6 Global Preclinical CRO Market Competition by Manufacturers
6.1 Global Preclinical CRO Revenue and Share by Manufacturers (2015-2019) 

Chapter 7 Company (Top Players) Profiles and Key Data
7.1 PAREXEL International Corporation 
            7.1.1 Basic Information and Sales Area
            7.1.2 Business Segment/ Overview
            7.1.3 Investment in Research and Development
            7.1.4 Preclinical CRO Product Types Specification
            7.1.5 Key Developments
            7.1.6 Business Strategy
7.2 Envigo
            7.2.1 Basic Information and Sales Area
            7.2.2 Business Segment/ Overview
            7.2.3 Investment in Research and Development
            7.2.4 Preclinical CRO Product Types Specification
            7.2.5 Business Strategy
7.3 Charles River
            7.3.1 Basic Information, and Sales Area
            7.3.2 Business Segment/ Overview
            7.3.3 Preclinical CRO Product Types Specification
            7.3.4 Key Developments
            7.3.5 Business Strategy
7.4 IQVIA
            7.4.1 Basic Information and Sales Area. 
            7.4.2 Business Segment/ Overview
            7.4.3 Preclinical CRO Product Types Specification
            7.4.4 Business Strategy
7.5 ICON plc
            7.5.1 Basic Information and Sales Area. 
            7.5.2 Business Segment/ Overview
            7.5.3 Preclinical CRO Product Types Specification
            7.5.4 Business Strategy
7.6 Eurofins Scientific
            7.6.1 Basic Information, and Sales Area
            7.6.2 Business Segment/ Overview
            7.6.3 Preclinical CRO Product Types Specification
            7.6.4 Business Strategy
7.7 PRA Health Sciences 
            7.7.1 Basic Information, and Sales Area
            7.7.2 Business Segment/ Overview
            7.7.3 Investment in Research and Development
            7.7.4 Preclinical CRO Product Types Specification
            7.7.5 Key Developments
            7.7.6 Business Strategy
7.8 Medpace
            7.8.1 Basic Information and Sales Area. 
            7.8.2 Business Segment/ Overview
            7.8.3 Preclinical CRO Product Types Specification
            7.8.4 Business Strategy
7.9 WuXi AppTec
            7.9.1 Basic Information, and Sales Area
            7.9.2 Business Segment/ Overview
            7.9.3 Preclinical CRO Product Types Specification
            7.9.4 Business Strategy
7.10 Pharmaceutical Product Development, LLC
            7.10.1 Basic Information, and Sales Area
            7.10.2 Business Segment/ Overview
            7.10.3 Preclinical CRO Product Types Specification
            7.10.4 Business Strategy
            
Chapter 8 Global Preclinical CRO Revenue by Regions (2015-2020) 
8.1 Global Preclinical CRO Revenue and Market Share (%) by Regions (2015-2020) 

Chapter 9 Global Preclinical CRO Revenue by Types
9.1 Global Preclinical CRO Revenue and Market Share (%) by Types (2015-2020) 

Chapter 10 Global Preclinical CRO Market Analysis by Application
10.1 Global Preclinical CRO Revenue (USD Million) and Market Share (%) by Application (2015-2020) 
10.2 Global Preclinical CRO Revenue Growth Rate by Application (2015-2020) 

Chapter 11 North America Preclinical CRO Market Development Status and Outlook
11.1 North America Preclinical CRO Market Size (2015-2020) 
            11.1.1 North America Preclinical CRO Market Size by Type (USD Million) (2015-2020) 
11.2 North America Preclinical CRO Market Size (2015-2020) 
            11.2.1 North America Preclinical CRO Market Size by Application (USD Million) (2015-2020) 
11.3 U.S
            11.3.1 U.S. Preclinical CRO market, by Type, 2015 - 2027
            11.3.2 U.S. Preclinical CRO market, by Application, 2015 – 2027
11.4 Canada
            11.4.1 Canada Preclinical CRO market, by Type, 2015 - 2027
            11.4.2 Canada Preclinical CRO market, by Application, 2015 – 2027
11.5 Mexico
            11.5.1 Mexico Preclinical CRO market, by Type, 2015 - 2027
            11.5.2 Mexico Preclinical CRO market, by Application, 2015 – 2027
            
Chapter 12 Europe Preclinical CRO Market Development Status and Outlook
12.1 Europe Preclinical CRO Market Size (2015-2020) 
            12.1.1 Europe Preclinical CRO Market Size by Type (USD Million) (2015-2020) 
12.2 Europe Preclinical CRO Market Size (2015-2020) 
            12.2.1 Europe Preclinical CRO Market Size by Application (USD Million) (2015-2020) 
12.3 U.K.
            12.3.1 U.K. Preclinical CRO market, by Type, 2015 - 2027
            12.3.2 U.K. Preclinical CRO market, by Application, 2015 – 2027
12.4 Germany
            12.4.1 Germany Preclinical CRO market, by Type, 2015 - 2027
            12.4.2 Germany Preclinical CRO market, by Application, 2015 – 2027
12.5 France
            12.5.1 France Preclinical CRO market, by Type, 2015 – 2027
            12.5.2 France Preclinical CRO market, by Application, 2015 – 2027
12.6 Italy
            12.6.1 Italy Preclinical CRO market, by Type, 2015 – 2027
            12.6.2 Italy Preclinical CRO market, by Application, 2015 – 2027
12.7 Spain
            12.7.1 Spain Preclinical CRO market, by Type, 2015 – 2027
            12.7.2 Spain Preclinical CRO market, by Application, 2015 – 2027
12.8 Rest of Europe
            12.8.1 Rest of Europe Preclinical CRO market, by Type, 2015 – 2027
            12.8.2 Rest of Europe Preclinical CRO market, by Application, 2015 – 2027
            
Chapter 13 Asia Pacific Preclinical CRO Market Development Status and Outlook
13.1 Asia Pacific Preclinical CRO Market Size (2015-2020) 
            13.1.1 Asia Pacific Preclinical CRO Market Size by Type (USD Million) (2015-2020) 
13.2 Asia Pacific Preclinical CRO Market Size (2015-2020) 
            13.2.1 Asia Pacific Preclinical CRO Market Size by Application (USD Million) (2015-2020) 
13.3 China
            13.3.1 China Preclinical CRO market, by Type, 2015 – 2027
            13.3.2 China Preclinical CRO market, by Application, 2015 – 2027
13.4 Japan
            13.4.1 Japan Preclinical CRO market, by Type, 2015 – 2027
            13.4.2 Japan Preclinical CRO market, by Application, 2015 – 2027
13.5 India
            13.5.1 India Preclinical CRO market, by Type, 2015 – 2027
            13.5.2 India Preclinical CRO market, by Application, 2015 – 2027
13.6 Southeast Asia
            13.6.1 Southeast Asia Preclinical CRO market, by Type, 2015 – 2027
            13.6.2 Southeast Asia Preclinical CRO market, by Application, 2015 – 2027
            
Chapter 14 South America Preclinical CRO Market Development Status and Outlook
14.1 South America Preclinical CRO Market Size (2015-2020) 
            14.1.1 South America Preclinical CRO Market Size by Type (USD Million) (2015-2020) 
14.2 South America Preclinical CRO Market Size (2015-2020) 
            14.2.1 South America Preclinical CRO Market Size by Application (USD Million) (2015-2020) 
14.3 Brazil
            14.3.1 Brazil Preclinical CRO market, by Type, 2015 – 2027
            14.3.2 Brazil Preclinical CRO market, by Application, 2015 – 2027 
14.4 Argentina
            14.4.1 Argentina Preclinical CRO market, by Type, 2015 – 2027
            14.4.2 Argentina Preclinical CRO market, by Application, 2015 – 2027 
14.5 Colombia
            14.5.1 Colombia Preclinical CRO market, by Type, 2015 – 2027
            14.5.2 Colombia Preclinical CRO market, by Application, 2015 – 2027
14.6 Rest of South America
            14.6.1 Colombia Preclinical CRO market, by Type, 2015 – 2027
            14.6.2 Colombia Preclinical CRO market, by Application, 2015 – 2027
            
Chapter 15 Middle East & Africa Preclinical CRO Market Development Status and Outlook
15.1 Middle East & Africa Preclinical CRO Market Size (2015-2020) 
            15.1.1 Middle East & Africa Preclinical CRO Market Size by Type (USD Million) (2015-2020) 
15.2 Middle East & Africa Preclinical CRO Market Size (2015-2020) 
            15.2.1 Middle East & Africa Preclinical CRO Market Size by Application (2015-2020) 
15.3 UAE
            15.3.1 UAE Preclinical CRO market, by Type, 2015 – 2027
            15.3.2 UAE Preclinical CRO market, by Application, 2015 – 2027
15.4 South Africa
            15.4.1 South Africa Preclinical CRO market, by Type, 2015 – 2027
            15.4.2 South Africa Preclinical CRO market, by Application, 2015 – 2027
15.5 Egypt
            15.5.1 Egypt Preclinical CRO market, by Type, 2015 – 2027
            15.5.2 Egypt Preclinical CRO market, by Application, 2015 – 2027
15.6 Rest of MEA
            15.6.1 Rest of MEA Preclinical CRO market, by Type, 2015 – 2027
            15.6.2 Rest of MEA Preclinical CRO market, by Application, 2015 – 2027
            
Chapter 16 Preclinical CRO Manufacturing Cost Analysis
16.1 Proportion of Manufacturing Cost Structure
            16.1.1 Raw Materials
            16.1.2 Labor Cost
            16.1.3 USA Labor Cost Analysis
            16.1.4 EU Labor Costs Analysis
            16.1.5 China Labor Costs Analysis
            16.1.6 Manufacturing Expenses
            
Chapter 17 Marketing Strategy Analysis, Distributors/ Traders
17.1 Marketing Channel
            17.1.1 Direct Marketing
            17.1.2 Indirect Marketing
            17.1.3 Marketing Channel Development Trend
17.2 Market Positioning
            17.2.1 Pricing Strategy
            
Chapter 18 Global Preclinical CRO Market Forecast (2020-2027) 
18.1 Global Preclinical CRO Revenue Forecast (2020-2027) 
            18.1.1 Global Preclinical CRO Revenue (USD Million) and Growth Rate (%) Forecast (2020-2027) 
18.2 Global Preclinical CRO Revenue (USD Million) Forecast by Regions (2020-2027) 
            18.2.1 North America Preclinical CRO Revenue (USD Million) Forecast (2020-2027) 
            18.2.2 Europe Preclinical CRO Revenue (USD Million) Forecast (2020-2027) 
            18.2.3 Asia Pacific Preclinical CRO and Revenue (USD Million) Forecast (2020-2027) 
            18.2.4 South America Preclinical CRO and Revenue (USD Million) Forecast (2020-2027) 
            18.2.5 Middle East & Africa Preclinical CRO and Revenue (USD Million) Forecast (2020-2027) 
18.3 Global Preclinical CRO Revenue Forecast by Type (2020-2027) 
18.4 Global Preclinical CRO Revenue (USD Million) Forecast by Application (2020-2027) 

Chapter 19 North America Preclinical CRO Market Development Status and Outlook
19.1 North America Preclinical CRO Market Size (2020-2027) 
            19.1.1 North America Preclinical CRO Market Size by Type (USD Million) (2020-2027) 
19.2 North America Preclinical CRO Market Size (2020-2027) 
            19.2.1 North America Preclinical CRO Market Size by Application (USD Million) (2020-2027) 
19.3 U.S.
            19.3.1 U.S. Preclinical CRO market, by Type, 2020 – 2027
            19.3.2 U.S. Preclinical CRO market, by Application, 2020 – 2027
19.4 Canada
            19.4.1 Canada Preclinical CRO market, by Type, 2020 – 2027
            19.4.2 Canada Preclinical CRO market, by Application, 2020 – 2027
19.5 Mexico
            19.5.1 Mexico Preclinical CRO market, by Type, 2020 – 2027
            19.5.2 Mexico Preclinical CRO market, by Application, 2020 – 2027
            
Chapter 20 Europe Preclinical CRO Market Development Status and Outlook
20.1 Europe Preclinical CRO Market Size (2020-2027) 
            20.1.1 Europe Preclinical CRO Market Size by Type (USD Million) (2020-2027) 
20.2 Europe Preclinical CRO Market Size (2020-2027) 
            20.2.1 Europe Preclinical CRO Market Size by Application (USD Million) (2020-2027) 
20.3 U.K.
            20.3.1 U.K. Preclinical CRO market, by Type, 2020 – 2027
            20.3.2 U.K. Preclinical CRO market, by Application, 2020 – 2027
20.4 Germany
            20.4.1 Germany Preclinical CRO market, by Type, 2020 – 2027
            20.4.2 Germany Preclinical CRO market, by Application, 2020 – 2027
20.5 France
            20.5.1 France Preclinical CRO market, by Type, 2020 – 2027
            20.5.2 France Preclinical CRO market, by Application, 2020 – 2027
20.6 Italy
            20.6.1 France Preclinical CRO market, by Type, 2020 – 2027
            20.6.2 France Preclinical CRO market, by Application, 2020 – 2027
20.7 Spain
            20.7.1 France Preclinical CRO market, by Type, 2020 – 2027
            20.7.2 France Preclinical CRO market, by Application, 2020 – 2027
20.8 Rest of Europe
            20.8.1 France Preclinical CRO market, by Type, 2020 – 2027
            20.8.2 France Preclinical CRO market, by Application, 2020 – 2027
            
Chapter 21 Asia Pacific Preclinical CRO Market Development Status and Outlook
21.1 Asia Pacific Preclinical CRO Market Size (2020-2027) 
            21.1.1 Asia Pacific Preclinical CRO Market Size by Type (USD Million) (2020-2027) 
21.2 Asia Pacific Preclinical CRO Market Size (2020-2027) 
            21.2.1 Asia Pacific Preclinical CRO Market Size by Application (USD Million) (2020-2027) 
21.3 China
            21.3.1 China Preclinical CRO market, by Type, 2020 – 2027
            21.3.2 China Preclinical CRO market, by Application, 2020 – 2027
21.4 Japan
            21.4.1 Japan Preclinical CRO market, by Type, 2020 – 2027
            21.4.2 Japan Preclinical CRO market, by Application, 2020 – 2027
21.5 India
            21.5.1 India Preclinical CRO market, by Type, 2020 – 2027
            21.5.2 India Preclinical CRO market, by Application, 2020 – 2027
21.6 Southeast Asia
            21.6.1 Southeast Asia Preclinical CRO market, by Type, 2020 – 2027
            21.6.2 Southeast Asia Preclinical CRO market, by Application, 2020 – 2027
            
Chapter 22 South America Preclinical CRO Market Development Status and Outlook
22.1 South America Preclinical CRO Market Size (2020-2027) 
            22.1.1 South America Preclinical CRO Market Size by Type (USD Million) (2020-2027) 
22.2 South America Preclinical CRO Market Size (2020-2027) 
            22.2.1 South America Preclinical CRO Market Size by Application (USD Million) (2020-2027) 
22.3 Brazil
            22.3.1 Brazil Preclinical CRO market, by Type, 2020 – 2027
            22.3.2 Brazil Preclinical CRO market, by Application, 2020 – 2027 
22.4 Argentina
            22.4.1 Argentina Preclinical CRO market, by Type, 2020 – 2027
            22.4.2 Argentina Preclinical CRO market, by Application, 2020 – 2027 
22.5 Colombia
            22.5.1 Colombia Preclinical CRO market, by Type, 2020 – 2027
            22.5.2 Colombia Preclinical CRO market, by Application, 2020 – 2027
22.6 Rest of South America
            22.6.1 Colombia Preclinical CRO market, by Type, 2020 – 2027
            22.6.2 Colombia Preclinical CRO market, by Application, 2020 – 2027
            
Chapter 23 Middle East & Africa Preclinical CRO Market Development Status and Outlook
23.1 Middle East & Africa Preclinical CRO Market Size (2020-2027) 
            23.1.1 Middle East & Africa Preclinical CRO Market Size by Type (USD Million) (2020-2027) 
23.2 Middle East & Africa Preclinical CRO Market Size (2020-2027) 
            23.2.1 Middle East & Africa Preclinical CRO Market Size by Application (USD Million) (2020-2027) 
23.3 UAE
            23.3.1 UAE Preclinical CRO market, by Type, 2020 – 2027
            23.3.2 UAE Preclinical CRO market, by Application, 2020 – 2027
23.4 South Africa
            23.4.1 South Africa Preclinical CRO market, by Type, 2020 – 2027
            23.4.2 South Africa Preclinical CRO market, by Application, 2020 – 2027
23.5 Egypt
            23.5.1 Egypt Preclinical CRO market, by Type, 2020 – 2027
            23.5.2 Egypt Preclinical CRO market, by Application, 2020 – 2027
24.6 Rest of MEA
            24.6.1 Rest of MEA Preclinical CRO market, by Type, 2020 – 2027
            24.6.2 Rest of MEA Preclinical CRO market, by Application, 2020 – 2027
            
Chapter 25 Research Findings and Conclusion

 

No Methodology

Global Preclinical CRO Market Trends:
The global preclinical CRO market is estimated to be worth USD 4,100 million in 2019 and is projected to reach USD 7,759 million by 2027, at a CAGR of 8.3% from 2020 to 2027.

A Preclinical CRO also referred to as a preclinical contract research organization. A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The entire journey involves plenty of exercises that perhaps include researchers, restorative workforce, legislative and industry contacts, specialists, and a large group of other specialized and innovative people. Moreover, any new medications or gadgets are first tested in preclinical preliminaries and then tried on people to ensure that it is sheltered and successful.

According to current market condition, the market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trend, which is expected to increase the demand for preclinical trials in the future. The market is expected to witness profitable growth in the coming future due to increase in R&D spending in the early stage of advancement along with the rise in a number of medicines in the preclinical stage. Hence, growth in outsourcing penetration is likely to contribute to the increasing demand and popularity of several life science companies particularly for outsourced preclinical (CRO) treatment. However, lack of standardization to regulatory policies, scarcity of labor & high labor cost can restrict the growth for the preclinical CRO market in the near future.

Global Preclinical CRO Market, By Type:
Based on type, the preclinical CRO market is categorized into bioanalysis and DMPK studies, toxicology testing, and others. Toxicology testing holds the largest share in the global market, since it is an important part of Investigational New Drug (IND)-enabling studies. Due to rise in outsourcing of noncore preclinical CRO studies, the market is expected to grow considerably during the forecast period.
 
Global Preclinical CRO Market, By Application:
Based on application, the preclinical CRO market is categorized into Biopharmaceutical companies, Government and academic institutes, Medical device companies and Others. Biopharmaceutical companies end-use segment will contribute to significant market share. High segmental share is attributable to growing focus of the firms to reduce R&D expenditure. Increase in number of drug entities owing to growing competition and disease burden will propel biopharmaceutical companies growth. Moreover, stringent regulatory requirements for drugs and biopharmaceutical products should impel segmental growth in forthcoming years.

Global Preclinical CRO Market, By Region:
On the basis of region, global preclinical CRO market includes North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Geographically, North America dominated the market and is expected to remain dominant throughout the forecast period owing to increasing R&D in and increasing adoption of new technology in medical devices. Increased availability of skilled human resources and low cost of devices are also the factors anticipated to drive the market growth over the forecast period. Demand for preclinical CRO services is rising owing to increasing prevalence of chronic diseases, thus fueling the regional market growth. North America region is followed by Asia pacific and Europe.

Major Market Players:
The research study includes profiles of leading companies operating in the global preclinical CRO market. Key players profiled in the report include: PAREXEL International Corporation, Envigo, Charles River, IQVIA, ICON plc, Eurofins Scientific, PRA Health Sciences (PRA), Medpace, Laboratory Corporation of America Holdings, WuXi AppTec, Pharmaceutical Product Development, LLC, and MD Biosciences.

Global Preclinical CRO Market Report Scope:
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Million)
Covered Segments Product Type, Applications, Geographic Regions
Product Type Bioanalysis and DMPK studies, Toxicology testing and Others
Applications Biopharmaceutical companies, Government and academic institutes, Medical device companies and Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered PAREXEL International Corporation, Envigo, Charles River, IQVIA, ICON plc, Eurofins Scientific, PRA Health Sciences (PRA), Medpace, Laboratory Corporation of 
America Holdings, WuXi AppTec, Pharmaceutical Product Development, LLC, and MD Biosciences

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global preclinical CRO market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global Preclinical CRO Market: Product analysis
  • Bioanalysis and DMPK studies
  • Toxicology testing
  • Others
Global Preclinical CRO Market: Application analysis
  • Biopharmaceutical companies
  • Government and academic institutes
  • Medical device companies
  • Others
Market, by regions:
In addition, global preclinical CRO market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)
 
 
 
 

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase